Sector valuations Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
03/09/2026
|
5-day change | 1st Jan Change | ||
| 233.98 CHF | +0.82% |
|
-3.43% | - |
| 08-20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 33.99x | 4.54x | 1.27x | 6.09x | 18.25x | 25.55x | 0.94% | 50.35B | ||
| -21.55x | 22.29x | -0.33x | 255.32x | -23.29x | -21.83x | -.--% | 45.2B | ||
| 34.98x | 6.39x | -36.55x | 3.36x | 14.51x | 21.92x | -.--% | 44.71B | ||
| 47.51x | 8.04x | 0.24x | 5.49x | 30.13x | 34.67x | -.--% | 41.24B | ||
| 28.36x | 2.31x | 0.58x | 8.58x | 21.72x | 25.76x | 0.41% | 33.08B | ||
| 33.74x | 24.21x | 2.24x | 5.53x | 25.11x | 26.27x | -.--% | 16.56B | ||
| 24.49x | 2.74x | 0.71x | 2.12x | 9.19x | 14.22x | 1.1% | 14.82B | ||
| 78.47x | 4.65x | -0.34x | 4.12x | 15.98x | 19.63x | -.--% | 14B | ||
| 27.77x | 1.32x | 0.27x | 1.84x | 11.28x | 12.85x | -.--% | 12.62B | ||
| 52.44x | 4.57x | 2.74x | 8.7x | 24.7x | 29.46x | 0.44% | 11.36B | ||
| -46.03x | 23.72x | 123.15x | 7.64x | 187.04x | -2487.96x | -.--% | 11.67B | ||
| 39.63x | 4.56x | 2.56x | 4.67x | 20.22x | 32.15x | 0.57% | 10.81B | ||
| -27.96x | 8.23x | 1.05x | 109.1x | -31.06x | -54.04x | -.--% | 10.78B | ||
| -15.97x | 672.96x | -0.3x | 10.46x | -16.77x | -16.19x | -.--% | 9.66B | ||
| -320.19x | 2.53x | 3.4x | 11.4x | 68.14x | 89.68x | -.--% | 10.13B | ||
| -25.57x | 8.83x | -8.37x | 10681.55x | -21.1x | -20.78x | -.--% | 9.92B | ||
| -30.56x | 8.8x | -7.66x | 79.59x | -20.23x | -19.74x | -.--% | 9.75B | ||
| 32x | - | -0.1x | 16.76x | 30.59x | 29.89x | -.--% | 9.63B | ||
| Average | -3.03x | 47.69x | 4.70x | 623.46x | 20.25x | -125.47x | 0.19% | 20.35B | |
| Weighted average by Cap. | 11.24x | 26.97x | -0.36x | 330.89x | 16.81x | -64.55x | 0.24% |
Select your edition
All financial news and data tailored to specific country editions
















